INVO Fertility, Inc. (IVF)
NASDAQ: IVF · Real-Time Price · USD
2.240
+0.050 (2.28%)
At close: Jul 25, 2025, 4:00 PM
2.180
-0.060 (-2.68%)
After-hours: Jul 25, 2025, 7:53 PM EDT

Company Description

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients.

It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body.

It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody.

The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025.

INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

INVO Fertility, Inc.
INVO Fertility logo
CountryUnited States
Founded2007
IndustryMedical Devices
SectorHealthcare
Employees37
CEOSteven Shum

Contact Details

Address:
5582 Broadcast Court
Sarasota, Florida 34240
United States
Phone978-878-9505
Websiteinvobioscience.com

Stock Details

Ticker SymbolIVF
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001417926
ISIN NumberUS44984F6097

Key Executives

NamePosition
Steven M. ShumChief Executive Officer and Director
Dr. Daniel Gedeon Teper MBA, PharmDPresident and Director
Andrea GorenChief Financial Officer
Lyn FalconioChief Communications Officer